• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲基化酶FTO通过以m6A方式上调EGR2表达来抑制前列腺癌的发展。

Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.

作者信息

Wang Zhenyu, Sun Huamin, Zhu Hua, Gu Donghua, Chen Xinfeng, Pan Yongsheng, Zheng Bing, Yang Dongrong

机构信息

Department of Urology, The Second Affiliated Hospital of Soochow University, Jiangsu, China.

Department of Urology, The Second Affiliated Hospital of Nantong University, Jiangsu, China.

出版信息

Turk J Biol. 2022 Oct 13;46(6):426-438. doi: 10.55730/1300-0152.2629. eCollection 2022.

DOI:10.55730/1300-0152.2629
PMID:37529797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10387994/
Abstract

Fat mass and obesity-associated protein (FTO) is a demethylase and plays a vital role in various cancers. However, the regulation mechanism of FTO in prostate cancer (PCa) remains unclear. This study aimed to elucidate the mechanism of FTO in PCa. The function and mechanism of FTO-mediated in PCa were determined by gain-of-function assays and RNA-seq. We found that FTO expression in PCa tissues and two PCa cell lines were significantly lower than that in adjacent tissues and normal cell line. PCa cells after overexpression of FTO showed a significant lower in proliferation, migration, and invasion capabilities. RNA-seq displayed that FTO overexpression altered transcriptome landscape in Du145 and PC-3 cells, particularly upregulating EGR2 expression. FTO overexpression induced differential expression genes, including MYLK2, DNA2, CDK, and CDC (6, 7, 20, 25, and 45), which were mainly enriched in adjustment of cell cycle and growth pathways. Furthermore, FTO overexpression significantly reduced the EGR2 methylation level. Arresting the proliferation, migration, and invasion of Du145 cells induced by FTO overexpression was significantly rescued by EGR2 knockdown. FTO overexpression also significantly inhibited tumor growth and promoted EGR2 protein expression. Taken together, FTO suppresses PCa progression by regulating EGR2 methylation. We uncovered a novel regulatory mechanism of FTO in PCa and provide a new potential therapeutic target for PCa.

摘要

脂肪量和肥胖相关蛋白(FTO)是一种去甲基化酶,在多种癌症中发挥着至关重要的作用。然而,FTO在前列腺癌(PCa)中的调控机制仍不清楚。本研究旨在阐明FTO在PCa中的作用机制。通过功能获得实验和RNA测序确定了FTO在PCa中介导的功能和机制。我们发现,PCa组织和两种PCa细胞系中FTO的表达明显低于相邻组织和正常细胞系。FTO过表达后的PCa细胞在增殖、迁移和侵袭能力方面显著降低。RNA测序显示,FTO过表达改变了Du145和PC-3细胞中的转录组格局,特别是上调了EGR2的表达。FTO过表达诱导了差异表达基因,包括MYLK2、DNA2、CDK以及CDC(6、7、20、25和45),这些基因主要富集在细胞周期和生长途径的调节中。此外,FTO过表达显著降低了EGR2的甲基化水平。通过敲低EGR2可显著挽救FTO过表达诱导的Du145细胞的增殖、迁移和侵袭的抑制。FTO过表达还显著抑制肿瘤生长并促进EGR2蛋白表达。综上所述,FTO通过调节EGR2甲基化抑制PCa进展。我们揭示了FTO在PCa中的一种新的调控机制,并为PCa提供了一个新的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/891af07ea5b7/turkjbiol-46-6-426f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/39f54dccf592/turkjbiol-46-6-426f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/5b64f662f020/turkjbiol-46-6-426f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/35f6e713d7a0/turkjbiol-46-6-426f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/9103fbbdd84a/turkjbiol-46-6-426f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/aa5ffc2f48f2/turkjbiol-46-6-426f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/403bfd07f66e/turkjbiol-46-6-426f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/92916ad958ba/turkjbiol-46-6-426f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/891af07ea5b7/turkjbiol-46-6-426f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/39f54dccf592/turkjbiol-46-6-426f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/5b64f662f020/turkjbiol-46-6-426f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/35f6e713d7a0/turkjbiol-46-6-426f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/9103fbbdd84a/turkjbiol-46-6-426f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/aa5ffc2f48f2/turkjbiol-46-6-426f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/403bfd07f66e/turkjbiol-46-6-426f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/92916ad958ba/turkjbiol-46-6-426f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b45/10387994/891af07ea5b7/turkjbiol-46-6-426f8.jpg

相似文献

1
Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.去甲基化酶FTO通过以m6A方式上调EGR2表达来抑制前列腺癌的发展。
Turk J Biol. 2022 Oct 13;46(6):426-438. doi: 10.55730/1300-0152.2629. eCollection 2022.
2
N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.N6-甲基腺苷去甲基化酶FTO通过维持CLIC4 mRNA稳定性抑制前列腺癌进展。
Cell Death Discov. 2022 Apr 9;8(1):184. doi: 10.1038/s41420-022-01003-7.
3
N-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.N-甲基腺苷RNA去甲基化酶FTO通过下调ITGB1的m6A甲基化促进胃癌转移。
Front Oncol. 2021 Jul 1;11:681280. doi: 10.3389/fonc.2021.681280. eCollection 2021.
4
Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).去甲基化酶 FTOα-酮戊二酸依赖双加氧酶(FTO)通过调节黑素皮质素 4 受体(MC4R)的表达来调节前列腺癌的增殖、迁移、侵袭和肿瘤生长。
Bioengineered. 2022 Mar;13(3):5598-5612. doi: 10.1080/21655979.2021.2001936.
5
Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth and in a murine model.靶向脂肪量与肥胖相关蛋白可减轻人类结直肠癌的生长,并在小鼠模型中得到验证。
Front Oncol. 2023 Feb 17;13:1087644. doi: 10.3389/fonc.2023.1087644. eCollection 2023.
6
m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.m6A去甲基化酶FTO通过调节食管癌中的脂质代谢促进肿瘤进展。
Cell Biosci. 2022 May 14;12(1):60. doi: 10.1186/s13578-022-00798-3.
7
mA RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.mA RNA 去甲基酶 FTO 通过抑制 TFPI-2 促进胰腺癌细胞的生长、迁移和侵袭。
Epigenetics. 2022 Dec;17(12):1738-1752. doi: 10.1080/15592294.2022.2061117. Epub 2022 Apr 11.
8
The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.FTO/miR-181b-3p/ARL5B 信号通路调控乳腺癌细胞迁移和侵袭。
Cancer Commun (Lond). 2020 Oct;40(10):484-500. doi: 10.1002/cac2.12075. Epub 2020 Aug 17.
9
The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.FTO介导的DDIT4的N6-甲基腺苷修饰与前列腺癌的肿瘤发生和转移调控
Research (Wash D C). 2024 Feb 21;7:0313. doi: 10.34133/research.0313. eCollection 2024.
10
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.m6A 去甲基酶 FTO 通过调节 USP7 mRNA 的 m6A 水平促进肺癌细胞的生长。
Biochem Biophys Res Commun. 2019 May 7;512(3):479-485. doi: 10.1016/j.bbrc.2019.03.093. Epub 2019 Mar 21.

引用本文的文献

1
Biological interpretation of DNA/RNA modification by ALKBH proteins and their role in human cancer.ALKBH蛋白对DNA/RNA修饰的生物学解读及其在人类癌症中的作用。
Eur J Med Res. 2025 Jun 6;30(1):458. doi: 10.1186/s40001-025-02735-9.
2
Mechanism of TGIF1 on glycolipid metabolism disorders in mice with type 2 diabetes.TGIF1对2型糖尿病小鼠糖脂代谢紊乱的作用机制
BMJ Open Diabetes Res Care. 2025 Jan 21;13(1):e004509. doi: 10.1136/bmjdrc-2024-004509.
3
The mA regulators in prostate cancer: molecular basis and clinical perspective.

本文引用的文献

1
N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.N6-甲基腺苷去甲基化酶FTO通过维持CLIC4 mRNA稳定性抑制前列腺癌进展。
Cell Death Discov. 2022 Apr 9;8(1):184. doi: 10.1038/s41420-022-01003-7.
2
Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).去甲基化酶 FTOα-酮戊二酸依赖双加氧酶(FTO)通过调节黑素皮质素 4 受体(MC4R)的表达来调节前列腺癌的增殖、迁移、侵袭和肿瘤生长。
Bioengineered. 2022 Mar;13(3):5598-5612. doi: 10.1080/21655979.2021.2001936.
3
前列腺癌中的毫安调节器:分子基础与临床前景
Front Pharmacol. 2024 Aug 29;15:1448872. doi: 10.3389/fphar.2024.1448872. eCollection 2024.
4
Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors.肥胖相关蛋白的脂肪质量的药物化学方面:结构、功能和抑制剂。
Future Med Chem. 2024 Aug 17;16(16):1705-1726. doi: 10.1080/17568919.2024.2380245. Epub 2024 Aug 5.
5
RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations.RNA m6A甲基化调节因子在去势抵抗性前列腺癌进展中的表达及其遗传关联
Cancers (Basel). 2024 Mar 27;16(7):1303. doi: 10.3390/cancers16071303.
miR-25 Regulates Gastric Cancer Cell Growth and Apoptosis by Targeting EGR2.
miR-25通过靶向EGR2调控胃癌细胞的生长和凋亡。
Front Genet. 2021 Oct 26;12:690196. doi: 10.3389/fgene.2021.690196. eCollection 2021.
4
The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.m6A 调控基因在非小细胞肺癌中的病理组织表达模式及临床意义。
J Gene Med. 2022 Feb;24(2):e3397. doi: 10.1002/jgm.3397. Epub 2021 Dec 1.
5
FTO promotes tumour proliferation in bladder cancer via the FTO/miR-576/CDK6 axis in an m6A-dependent manner.FTO通过FTO/miR-576/CDK6轴以m6A依赖的方式促进膀胱癌的肿瘤增殖。
Cell Death Discov. 2021 Nov 1;7(1):329. doi: 10.1038/s41420-021-00724-5.
6
N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation YAP1.PTTG3P的N6-甲基腺苷修饰促进结直肠癌增殖 Yes相关蛋白1(YAP1)
Front Oncol. 2021 Sep 30;11:669731. doi: 10.3389/fonc.2021.669731. eCollection 2021.
7
m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating and inhibiting Wnt signaling.m6A去甲基化酶FTO通过去甲基化和抑制Wnt信号通路来抑制胰腺癌的肿瘤发生。
Mol Ther Nucleic Acids. 2021 Jun 24;25:277-292. doi: 10.1016/j.omtn.2021.06.005. eCollection 2021 Sep 3.
8
EGR2-mediated regulation of mA reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization.EGR2介导的mA阅读器IGF2BP蛋白调控通过增强S1PR3 mRNA稳定性驱动肾细胞癌的肿瘤发生和转移。
Cell Death Dis. 2021 Jul 29;12(8):750. doi: 10.1038/s41419-021-04038-3.
9
MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).MicroRNA-17-5p 通过抑制早期生长反应 2(EGR2)抑制甲状腺癌的进展。
Bioengineered. 2021 Dec;12(1):2713-2722. doi: 10.1080/21655979.2021.1935137.
10
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.TNMplot.com:一个用于比较正常、肿瘤和转移组织中基因表达的网络工具。
Int J Mol Sci. 2021 Mar 5;22(5):2622. doi: 10.3390/ijms22052622.